Znn3bq.jpeg
±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 272  |  »Ø¸´: 3
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

pku123

½ð³æ (ÕýʽдÊÖ)


[½»Á÷] ·­ÒëÒ»¾ä»°

Campillos et al. (2008) was the use of similarities in the sideeffects of known drugs to predict new drug-target interactions, some of which were verified by in vitro binding assays. The limitation of this approach is that it only applies to known side-effects of known drugs, thus limiting the ability of the method to perform
high-throughput screening of potential interactions between new molecules and proteins.

» ²ÂÄãϲ»¶

» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:

²é¿´È«²¿É¢½ðÌù

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
pku123(½ð±Ò+1, ·­ÒëEPI+1): 2011-03-04 09:37:38
pku123(½ð±Ò+1): 2011-03-05 07:32:19
ringzhu(½ð±Ò+16): ²»½âÊÍ~~ 2011-03-15 10:23:03
Campillos et al. (2008) was the use of similarities in the side effects of known drugs to predict new drug-target interactions, some of which were verified by in vitro binding assays. The limitation of this approach is that it only applies to known side-effects of known drugs, thus limiting the ability of the method to perform high-throughput screening of potential interactions between new molecules and proteins.
Campillos µÈ(2008)ÓÃÒ»Ö»Ò©ÎïµÄ¸±×÷ÓõÄÏàËÆÐÔÔ¤²âÐÂÒ©ºÍ°Ð±ê¼äµÄÏ໥×÷Óã¬ÆäÖÐһЩÏ໥×÷ÓÃÓÉÌåÄÚ½áºÏʹÓÃÈ·Ö¤¡£ÕâÖÖ·½·¨µÄ¾ÖÏÞÊÇËüÖ»Ó¦ÓÃÁËÒÑÖªÒ©ÎïµÄÒÑÖª¸±×÷Óã¬Òò´ËÏÞÖÆÁËÆäÔÚзÖ×Ӻ͵°°×ÖÊÖ®¼äDZÔÚÏ໥×÷ÓõĸßͨÁ¿É¸Ñ¡ÖеÄÓ¦Óá£
2Â¥2011-03-04 09:37:04
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
pku123(½ð±Ò+1): 2011-03-05 07:32:25
Campillos µÈ(2008)ÓÃÒÑÖªÒ©ÎïµÄ¸±×÷ÓõÄÏàËÆÐÔÔ¤²âÐÂÒ©ºÍ°Ð±ê¼äµÄÏ໥×÷Óã¬ÆäÖÐһЩÏ໥×÷ÓÃÓÉÌåÄÚ½áºÏÊÔÑéÈ·Ö¤¡£ÕâÖÖ·½·¨µÄ¾ÖÏÞÊÇËüÖ»Ó¦ÓÃÁËÒÑÖªÒ©ÎïµÄÒÑÖª¸±×÷Óã¬Òò´ËÏÞÖÆÁËÆäÔÚзÖ×Ӻ͵°°×ÖÊÖ®¼äDZÔÚÏ໥×÷ÓõĸßͨÁ¿É¸Ñ¡ÖеÄÓ¦Óá£
3Â¥2011-03-04 09:38:04
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
pku123(½ð±Ò+1): 2011-03-05 07:32:31
20¸ö£¿Ôõô1¸öbbÁËÊ£¿
4Â¥2011-03-04 11:12:58
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ pku123 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁÏר˶µ÷¼Á +14 ¹þ¹þ¹þºðºðºð¹þ 2026-04-07 15/750 2026-04-08 19:36 by cheerful9622
[¿¼ÑÐ] 085404£¬285·ÖÇóµ÷¼Á +4 Þ±Þ±¿¼ÑÐ 2026-04-07 4/200 2026-04-08 14:32 by zhq0425
[¿¼ÑÐ] 307Çóµ÷¼Á +14 ³¬¼¶ÒÁ°º´óÍõ 2026-04-06 14/700 2026-04-08 07:03 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 362Çóµ÷¼Á +8 ÎÒÒª¿¼´ó 2026-04-06 12/600 2026-04-08 00:32 by JourneyLucky
[¿¼ÑÐ] 277¡¢Ñ§Ë¶£¬Çóµ÷¼Á ÊýÒ»104£¬ +11 Æ¿×ÓPZ 2026-04-07 12/600 2026-04-07 23:30 by Ò»Ö»ºÃ¹û×Ó?
[¿¼ÑÐ] 318Çóµ÷¼Á +5 ÀîÇàɽɽɽ 2026-04-07 5/250 2026-04-07 18:24 by À¶ÔÆË¼Óê
[¿¼ÑÐ] »¯¹¤µ÷¼Á303·Ö£¬¹ýËļ¶ +34 ÆÜÎà´ý·ç 2026-04-02 34/1700 2026-04-07 12:30 by 1018329917
[ÂÛÎÄͶ¸å] Decision: Revise for Editor»¹»áËÍÉóÂð 100+3 CccccccccFD 2026-04-04 5/250 2026-04-07 10:58 by ±±¾©À³ÒðÈóÉ«
[¿¼ÑÐ] 26×ÔÈ»µØÀíѧ303·ÖÇóµ÷¼Á +4 Ò»Õ½³É˶°¡°¡°¡° 2026-04-06 9/450 2026-04-06 20:35 by lin-da
[¿¼ÑÐ] 071000ÉúÎïѧµ÷¼Á +7 À­ÌáÌÒ 2026-04-06 7/350 2026-04-06 18:55 by 52305043001
[¿¼ÑÐ] 0857´óÀà»·¾³¹¤³ÌBÇøÇóµ÷¼Á +3 ¹¨ÓíÃú 2026-04-05 3/150 2026-04-06 10:22 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 358Çóµ÷¼Á +7 Çïgk 2026-04-04 7/350 2026-04-05 13:29 by huangmoli
[¿¼ÑÐ] 341Çóµ÷¼Á +3 ѧÎÞÖ¹¾³£¬³å 2026-04-05 3/150 2026-04-05 09:40 by lbsjt
[¿¼ÑÐ] 290Çóµ÷¼Á +7 luoziheng 2026-04-04 7/350 2026-04-04 23:17 by lqwchd
[¿¼ÑÐ] 306Çóµ÷¼Á +3 hybÉÏÃû¹¤ 2026-04-02 3/150 2026-04-04 18:12 by ÈÈÇéɳĮ
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©¿Æ¼¼´óѧ²ÄÁϹ¤³Ì085601£¬Çóµ÷¼Á +17 cdyw 2026-04-02 18/900 2026-04-04 11:14 by w_xuqing
[¿¼ÑÐ] 278Çóµ÷¼Á +6 Yy7400 2026-04-03 6/300 2026-04-04 09:53 by zhangdingwa
[¿¼ÑÐ] 293Çóµ÷¼Á +5 ĩδmm 2026-04-02 6/300 2026-04-03 15:20 by Íõ±£½Ü33
[¿¼ÑÐ] »¯Ñ§070300-×Ü·Ö378-Çóµ÷¼Á +5 ŲÒÎ×ÓµÄÅÝÅÝÌÇ 2026-04-02 5/250 2026-04-02 22:20 by ZXlzxl0425
[¿¼ÑÐ] Çóµ÷¼Á +7 Aniyaio 2026-04-02 7/350 2026-04-02 16:42 by zzsw+
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û